First Page | Document Content | |
---|---|---|
Breast cancer Aromatase inhibitors Clinical trials AstraZeneca Study of Tamoxifen and Raloxifene Risk factors for breast cancer Tamoxifen Raloxifene Exemestane Medicine Chemistry Selective estrogen receptor modulators | Microsoft Word - ID[removed]video abstractAdd to Reading ListSource URL: www.ncbi.nlm.nih.govDownload Document from Source WebsiteFile Size: 302,28 KBShare Document on Facebook |
PDF DocumentDocID: 1xtSy - View Document | |
PDF DocumentDocID: 1x8mY - View Document | |
PDF DocumentDocID: 1wOXw - View Document | |
PDF DocumentDocID: 1wJ3B - View Document | |
PDF DocumentDocID: 1wie6 - View Document |